Chondrial Therapeutics' Series A Round

Chondrial Therapeutics raised a round of funding on February 01, 2017.

Chondrial Therapeutics is an emerging biotechnology company focused on the treatment of rare mitochondrial diseases. Chondrial's lead compound is CTI-1601, which the Company is developing as a potenti…

Articles about Chondrial Therapeutics' Series A Round: